Our previous study discovered that the blood MCP-1 level can modulate the genetic risks of AD for two established AD gene loci, APOE and HLA-DRB1.(18) However, there is no genome-wide search for the interaction effects between blood MCP-1 levels with genetic variants on AD risk. Here, CCL2 is linked to Alzheimer disease.